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Abstract 
Strategic alignment between business and information technology (IT) is considered key to maximizing 
IT impact. Nonetheless, only seldom have exceptional achievements in performance been studied from 
the viewpoint of the Strategic Alignment Model (SAM). This paper describes a longitudinal case study 
of a Health Maintenance Organization (HMO), named here MHMO, which serves over 1.7 million 
members. MHMO's management decided to support strategic business via alignment of business and 
IT, culminating in the implementation of a business process management (BPM) system to process and 
display performance measurement. Applying multivariate logistic regression analysis and qualitative 
analysis, we analyze the improvement in MHMO's clinical performance in comparison to all the
HMOs in the country between 2002 and 2005. The results clearly show a greater improvement for
MHMO in the period following the BPM system implementation in 2004. Plausible drivers of this 
achievement are discussed, paying special attention, via the lens of the Strategic Alignment Model, to 
the alignment between business and IT. Besides this paper's contribution in highlighting how business 
and IT can be aligned to achieve ambitious strategic goals, it demonstrates the feasibility and 
effectiveness of measuring quality of clinical care, generally considered a complex and costly mission. 
Keywords: Business and IT alignment, Strategic Alignment Model (SAM), Health Informatics, Quality 
of care, Multivariate logistic regression analysis, Quantitative research
1 INTRODUCTION
Strategic use of information technology (IT) has been the focus of many studies in the last decades
(Ross 2003). Most studies have emphasized the importance of aligning business and IT (Henderson 
and Venkatraman 1993) as a means to maximize the impact of IT on business performance. The 
importance of such alignment, however, has only seldom been empirically demonstrated in general, 
and in the healthcare industry in particular (Avison et al. 2004; Menachemi et al. 2006).
As healthcare expenses spiral, providers face growing pressures to control costs (Mossialos and Le 
Grand 1999; Schur et al. 2004), while still maintaining high quality patient care (Chassin 1996; 
Fendrick and Chernew 2006; Gray 1991; Iglehart 1996; Miller and Luft 1997). Most healthcare 
organizations, however, manage cost more closely than quality due to difficulties in acquiring the 
needed information to appropriately judge the level of clinical performance (Brook et al. 1996; 
Eisenberg 2002; Greenfield et al. 2002; McLoughlin and Leatherman 2003; Powell et al. 2003). 
Additionally, although there is a broad agreement that information systems facilitate collection, 
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processing, and distribution of measurement data, the healthcare industry is slower than other 
industries in utilizing IT for these purposes, typically treating IT as an expense rather than an enabler 
of enhanced business value (Menachemi et al. 2006; Spath 2007). Consequently, it is not common 
among healthcare organizations to seek strategic alignment between business and IT.
This paper presents the results of a longitudinal case study in Maccabi, a health maintenance 
organization (HMO) that participated, along with the other three HMOs in the country, in a project 
initiated by the national ministry of health aimed at comparing HMO quality of clinical care. In this 
nation-wide project, all four HMOs were required to collect and submit pre-defined, agreed-upon, data 
to measure the quality of health services. The ministry of health consolidated and publicized 
aggregated annual results (http://www.israelhpr.org.il), leaving the data per each HMO unpublished. 
In Maccabi, the studied HMO (hereinafter named MHMO), senior management thrived for business 
and IT alignment and implemented state-of-the-art information systems even before this national
measurement project was announced. MHMO chose to leverage its information systems to not only 
collect and process measurements data for the national quality-indicators project, but also to process 
and present a more comprehensive set of indicators, including costs as well as members satisfaction 
measures, organization-wide. Against a national improvement of quality of clinical care, results show 
that the improvement at MHMO significantly surpassed this of all other HMOs, while the average cost 
per patient remained unchanged. In-depth investigation of the results suggests that strategic alignment 
of business and IT in general, and particularly the implementation of a business process management 
(BPM) system, was a major driver of this exceptional improvement.
Three goals motivated this paper. First, to show how the mere act of measurement can drive quality 
improvement, even in the important, complex, and controversial domain of clinical care. Second, to
demonstrate how strategic business and IT alignment drove improvement of core business processes at
MHMO above and beyond its competitors, without incurring excessive costs. Finally, to point at 
lessons that other healthcare organizations can draw from this example of the benefits gained from 
aligning business and IT.
The next section presents a brief survey of the literature, followed by description of the case 
background and the methods used in this study. The results of the quantitative and qualitative analyses 
are presented in the fourth section, demonstrating clear relative improvements in the clinical aspects 
measured while containing costs. In conclusion, we discuss the role that information systems played at 
MHMO in improving the quality of clinical care from the perspective of the Strategic Alignment 
Model (Henderson & Venkatraman 1993). We then summarize the findings and lessons that can be 
drawn from this case in the healthcare industry and beyond.
2 LITERATURE SURVEY
Economics of organizational IT have remained a thorny issue for the past decades, as the direct 
contribution of IT to business performance is difficult to demonstrate (Brynjolfsson 1993; Carr 2003). 
Mixed results have been documented, with some research even showing negative correlation between 
IT investments and business performance (Kohli and Devaraj 2003). Yet, in spite of these
inconsistencies, there is broad agreement that strategic alignment between business and IT is key to
leveraging positive IT impact on business achievements (Avison et al. 2004; Henderson and 
Venkatraman 1993; Ross 2003). Business and IT alignment is defined as applying IT in an appropriate 
and timely way, in harmony with business strategies, goals and needs (Luftman et al. 1999). 
Several models presenting the implications of IT and business alignment have been suggested. The 
most frequently discussed models are the MIT90 model by (Scott Morton 1991) and the Strategic 
Alignment Model (SAM) by Henderson & Venkatraman (1993). In the latter, however, IT has been 
positioned for the first time at the same organizational level as the Business, emphasizing the role IT 
should play not only in supporting business strategy and processes, but also in shaping strategy and 
organizational structure. SAM suggests that in order for business and IT to align, at least three of four 
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organizational domains should be aligned: business strategy, IT strategy, business infrastructure, 
processes and skills, and IT infrastructure, processes, and skills. While the first two domains pertain to 
the external strategic perspective of the alignment impact, the latter two represent the internal resource 
perspective. In their alignment analysis, Henderson & Venkatraman identify four patterns of Business-
IT alignment that can facilitate organizational transformation: strategy execution, technology 
transformation, competitive potential, and service level. In the first two the alignment process leading 
to organizational transformation is driven by the business strategy, whereas in the last two the driver is 
IT strategy. 
SAM has inspired several studies, extending and refining the original model. For example, (Luftman 
2000) offered one extension by attempting a practical guide to either examining current Business and 
IT alignment in a firm, or discerning deficiencies in the required alignment. (Maes 1999) offered 
another extension by adding a layer between strategy and operation (termed structure), and a column 
between business and IT (termed information/communication). This extension, Maes maintains, lead 
to a more generic model of organizational information management. In addition, (Luftman et al. 1999)
identified six drivers and six inhibitors to business and IT alignment, with 'senior executive support for
IT' as the primary driver, and 'business/IT management lack close relationships' as the major inhibitor.
A few studies have demonstrated real-world achievements from the business and IT alignment 
perspective (Avison et al. 2004; Cooper et al. 2000; Heart et al. 2006), and none (as far as our 
literature search elicited) is from the healthcare industry (Bates et al. 1998; Mitchell and Sullivan 
2001; Powell et al. 2003; Spath 2007). Indeed, examination of IT investments indicates that the 
healthcare industry is lagging behind other industries in strategically harnessing IT for competitive 
advantage (Menachemi et al. 2006). Thus there is merit in presenting a case, showing how a business-
driven alignment can significantly contribute to achieving competitive edge in healthcare services.
3 METHODS
3.1 Case background
This paper describes a longitudinal case study conducted at MHMO, the second-largest HMO in a 
country where four HMOs jointly serve over 7 million people. MHMO employs over 3,000 physicians 
who treat more than 1.7 million members under an organizational structure consisting of headquarters, 
five regional offices, and approximately 150 branches (clinics and other entities as labs, imaging 
centres, etc.). Since the 1990s, MHMO has adopted, in addition to administrative systems, clinical 
information systems used by all care providers to document transactions associated with patient care, 
including visits, prescriptions, and test results. These information systems have allowed MHMO to 
collect and aggregate organization-wide operational data into a data warehouse (Friedman and Pliskin 
2002).
It is noteworthy that, as regulator of the national health insurance in the country, the ministry of health 
since 2002 has required all four HMOs to provide data about operational quality indicators for clinical 
care, which are being audited, processed, consolidated, and published (http://www.israelhpr.org.il) by 
The National Institute for Health Policy and Health Services Research (NIHP). NIHP also provides 
each HMO with its own performance indicators relative to the national performance
Coincidently, having by then in place a well-crafted business strategy aimed at improving the quality 
of clinical care while containing costs, MHMO’s top management commissioned in 2002 development
of the integrated hierarchical Health Value Added (HVA) model, based on the balanced scorecard 
(Kaplan and Norton 2007). HVA covers 21 performance measures, categorized into three major 
dimensions, each of which is composed of several areas. The six areas under the first clinical-quality
dimension are: diabetes, mammography, flu vaccinations, cardiovascular disease (CVD), depression, 
and appropriate use of antibiotics. The two areas under the second perceived-quality dimension are: 
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satisfaction and member retention. The two areas under the third cost dimension are: total cost per 
patient and conformance with budgetary objectives. Each of the ten areas is composed of several 
performance measures, the elaboration of which is beyond the scope of this paper except for the first 
dimension – clinical quality. 
In the clinical-quality area, each measure is defined as the percentage of members meeting the 
performance goal relative to the total target population for the specific area (see Appendix 1 for the 
full list of the 24 clinical measures). One of the diabetes measures, for example, is the percentage of 
patients among the total diabetic population, receiving a required screening test such as 
glycohemoglobin (HbA1C) once a year. Another area is vaccination, for which the total population 
includes members who are chronically ill and/or aged 55 and above. 
On the basis of the HVA model, an intranet-based Business Performance Management (BPM) system 
was built and implemented at MHMO for calculating and presenting performance scores relative to 
target goals at the headquarters, region, and branch levels, as well as national averages published by 
NIHP. Data for calculating performance were extracted from the existing data warehouse system,
storing routinely collected data and updated on a monthly basis. HVA measures were presented within 
the organization and approved during 2003, and the BPM system was up and running since February 
2004. Since then, the BPM system regularly presents actual MHMO performance against set targets,
to a broad organizational audience, and especially at monthly meetings of senior management. 
Since the set of HVA measures has included NIHP's national performance measures, the latter have 
been used by MHMO as a control group for comparison. Thus, for example, the total population for 
primary CVD prevention measure included 298,821 MHMO members and 760,095 other-HMOs 
members, for appropriate medications after bypass surgery - 1,302 and 13,412, and for
mammography - 128,309 and 495,607 for MHMO and other-HMOs members respectively. NIHP data 
is available for diabetes, mammography, and flu vaccination for 2002-2005, and for CVD for 2003-
2005. Because data is regularly published by NIHP, each HMO can compare its own indicators to 
those of the other three HMOs combined.
3.2 Data collection and analysis methods
Quantitative data underlying the analysis presented in this study are collected from primary 
organizational sources (Kohli and Devaraj 2003), and are identical to figures submitted to NIHP. 
These figures are thoroughly audited by NIHP to verify their correctness, attesting to their validity and 
objectivity. Similarly, qualitative data were scrutinized to ensure academic rigour (Friedman 2006).
A multivariate logistic regression analysis was used to assess the impact of various factors on  the 
performance of MHMO (Kohli and Devaraj 2003). Three dummy variables were defined for this 
analysis: the first reflecting changes over time for all HMOs (set equal 1 for the years 2004-5 and 0 
before), the second differentiating MHMO from all other HMOs (set equal 1 for MHMO and 0 for 
others), and the third variable, the interaction between the first and second variables, reflecting the 
changes at MHMO in 2004-5, after the implementation of the BPM system. The crude ratios of all 
measures over time are presented in Appendix 1. A graphical representation of the improvement rate is 
displayed in Appendix 2. The results of the multivariate logistic regression analysis are presented in 
Appendix 3 by Odds Ratio (OR) - the exponent of the appropriate coefficient of the logistic 
regression. OR indicates the increase (decrease for OR<1) in odds of the dependent variable being 
positive, based on a positive independent variable - with 95% confidence interval (CI). The two-sided 
(Wald) P-values, obtained from the logistic regression, were considered as significant under 0.05. All 
analyses were performed using SAS 9.1.3 (SAS Institute Inc. NC, US).  
Complementing the quantitative analysis, for triangulation purposes and for eliciting executives’ 
perceptions as to the major drivers of the improvement in clinical quality, qualitative data was 
collected at MHMO. The qualitative data were collected via semi-structured interviews with 29 key 
informants (selected so as to obtain a wide range of views), participant observations, and documentary 
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evidence (protocols, directives, transcripts, and work plans). Due to space limitations, the qualitative 
analysis is presented only briefly.
4 RESULTS
4.1 Quantitative results
As evident in Appendix 1, MHMO out-performed the other HMOs on 7 out of 9 diabetes (DM) 
measures (all but DM5 - % members with DM, with LDL<100, and DM6 - % members with DM,
with LDL<130). This advantage was kept throughout the four years of the study. While this might 
seem incidental, the superior improvement rate is even more impressive for the other measures. 
MHMO performance in the mammography area (Measure 10) was similar in 2002 to the performance 
of all other HMOs combined, went down in 2003 while the combined group of all other HMOs 
improved, but then gained 43% improvement by 2005 reaching 62.81%, compared to 1% 
improvement for all HMOs that only reached the level of 53.87%. In the area of flu vaccination 
(Measure 11) MHMO’s performance was initially similar to the combined group of all HMOs, yet 
MHMO was able to maintain a high level of improvement – 22%, three times better than all other 
HMOs, who started at a lower rate (42.57% compared to 51.51% for MHMO in 2003).
Comparison of the performance improvement (%) between the average of 2004-5 and the average of 
2002-3 for both MHMO and other HMOs is depicted by the bar chart in Appendix 2 (except where 
data were missing in 2002, in which case performance in the later period was compared to 2003). The 
chart shows that MHMO’s improvement rate was larger than that of the other HMOs for 14 of the 21 
measures, and the improvement was nearly identical for 2 measures. Only for 5 of the 21 measures the 
improvement rate of the other HMOs exceeded that of MHMO. In spite of initially performing better 
on most diabetes measures, MHMO’s improvement from 2003 to 2005 is greater than or equal to that 
of the other HMOs in 6 out of 9 DM measures. Even more notable is the improvement rate in the 10 
cardiovascular (CVD) measures. Here, MHMO achieved improvement rates greater than (or equal to 
for CVD2) all other HMOs for all measures but two (CVD1 and CVD5). Particularly remarkable is the 
improvement rate in CVD7 and CVD8, 102% and 78% respectively for MHMO, compared to 3% and 
-4% respectively for the other HMOs.
Next, a multivariate logistic regression analysis was performed to substantiate the results in a more 
illustrative manner, and to assess the effect of the BPM system. This analysis, presented in Appendix 
3, allows estimation of the impact of different factors, adjusting for the others. For each measure, the 
OR and its confidence interval (CI) are presented for the three covariates: Column 3 in Appendix 3 
presents the effects, pre-post the BPM system, on both MHMO and the other HMOs, and column 4 
presents the effect of being a member of MHMO during the four years. When comparing the 2002-
2003 period (pre-BPM) to the 2004-2005 period (post-BPM), it is evident that there was an 
improvement at the post-BPM period (Column 3) in all measures but two (DM2, CVD8) nation-wide. 
Note that DM3 is a negative measure, where a smaller value is better. The changes range from OR of 
1.973 in DM8 to OR of 1.015 for DM2.  All differences were statistically significant. Examination of 
Column 4 shows that for 10 out of 21 measures, MHMO performed better than the other HMOs for all 
measured years, since the calculated OR is greater than 1. All differences between MHMO and the 
other HMOs were statistically significant.
Column 5 in Appendix 3 demonstrates the potential positive effect of the actual introduction of the 
BPM system at MHMO in 2004-5 on achieving the rapid improvement pace. For 12 out of the 21 
measures, OR is greater then 1 (<1 for DM3), indicating that during 2004-5, MHMO not only 
performed statistically significantly better than in 2002-3, but also the rate of improvement was higher 
than it was for the other HMOs in these years. These results substantiate the evidence of accelerated 
rate of improvement displayed by the bar chart in Appendix 1, but suggest that the majority of 
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improvement has been achieved during the last two years of the study, after the introduction of the
BPM system.
Table 1 depicts the total costs (in 2005 values) per patient reported during 2002 to 2005, including 
spending on doctors, consultants and specialists, medications and treatments, and hospitalizations. As 
evident in Table 1, costs per patient in 2004 and 2005, when performance improvement has been most 
significant, are similar to (and somewhat lower then) those of 2002. Hence, the improvement in 
quality of clinical care has been achieved while containing costs. Budgetary goals were also reached as 
a result of cost stagnation.
2005200420032002Year
3,1893,1943,1833,219Cost per patient
Table 1: Costs per patient, 2002-2005 (in 2005 values)
4.2 Qualitative results
The implementation of the HVA model was followed by in-depth, semi-structured interviews with 29 
executives, representing a broad view of MHMO’s operations and management (Friedman 2006).  
Some of the questions in the interviews relate to the plausible explanations for the improvement in the 
various measures. In a response to an open question "what in your opinion caused the changes in 
performance", twenty six respondents (89.66%) ranked the process of clearly setting indicators and 
targets, which are presented in the BPM system, as the main reason for the improvement. Specifically, 
the visibility and credibility of the previously unavailable data, was said to have the main effect. "The 
BPM system allows an on-line update as part of our ongoing management. Without this tool it would 
have been impossible to achieve the current results". Furthermore, the interviewees maintained that 
having the measurement results regularly displayed, through the BPM system, in top management 
meetings and throughout the organization, was a major driver for competitive advantage and 
improvement. One interviewee even complained of "over measurement" and said that even though the 
BPM system was a driver for change, it took its toll on employees who were tired of the continuous 
exposure.
5 DISCUSSION
Notwithstanding the contribution of this case study, detailed next, several limitations should be noted. 
First, this case is an organizational-level study, where real-life, longitudinal field data is used, as 
opposed to experimental or laboratory data. Concerns about data accuracy might arise, as is often the 
case when using real-world data. Because real-life data have been used, the study cannot be classified 
as a “controlled” experiment. Nonetheless, the fact that the data used for this study is rigorously 
audited by NIHP, and the existence of objective, control-group data, provides the critical comparison 
required for rigour. Another concern is the large sample size, where significance is likely to be 
achieved at any case. While this might be true, the qualitative data reinforces the quantitative results, 
thus rejecting the likelihood of no real significance. Finally, concerns might arise as to the true process 
of aligning business strategy and IT at MHMO, since such alignment is often found at hindsight rather 
than as a systematically planned objective. Although we cannot be utterly positive this was not the 
case at MHMO, there is good evidence, mainly from the qualitative data not presented here in details, 
that management did consider alternative options for achieving the improvement goals, finally 
convinced about the effectiveness of the BPM system. This concern, however, still remains a 
somewhat questionable issue.
As evident from the 2002-2003 data, MHMO initially performed better on most indicators. Therefore, 
with all other factors being equal, the other HMOs should have demonstrated an accelerated 
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improvement rate since the organizational and the general health environment were stable and similar 
for all HMOs. This, however, was not the case for 16 out of 21 measures. More interestingly, the rate 
of improvement post-implementation of the BPM system was significantly greater for MHMO than 
for all other HMOs. This is evident in the results of the statistical multivariate logistic regression
analyses, substantiated by the qualitative data. Although performance was sporadically measured in 
MHMO during 2002 and 2003, the rapid pace of performance improvement is generally evident in 
2004 and 2005, when the strategic alignment between business and IT has matured. While 
investigating managerial drivers other than alignment (such as bonuses, already in existence in 2002-
2003), the major change in 2004-2005 was the organization-wide distribution of the results via the 
BPM system. During this period, not only clinical quality performance has improved, but also other 
indicators, such as members’ satisfaction and cost performance (Friedman 2006). Clearly, MHMO has 
succeeded in transforming its business processes to facilitate effective and more efficient clinical care, 
above and beyond its competitors, gaining competitive advantage. The improvement in quality of care 
at MHMO, while containing costs, can therefore be attributed to strategic business and IT alignment.
In the SAM context, the alignment perspective in this case is that of "strategy execution" (Henderson 
& Venkatraman, 1993, p. 477), where business strategy drives the organizational transformation, 
causing business and IT infrastructures to follow suit. MHMO’s business strategy was to gain
competitive edge by improving efficiency and effectiveness of clinical care. To achieve these 
ambitious goals, MHMO has successfully not only implemented, with support from business 
executives, information systems that facilitate efficiency and effectiveness of clinical care, such as
computerized medical records, data warehouse, and the BPM system, but also pursued major 
transformation in business infrastructures, processes, and skills. For example, all management levels 
transformed their managerial style to management by organization-set, quantifiable goals, as opposed 
to management by local interests and intuition, practiced before. Complying with Henderson and 
Venkatraman (1993), top management played the role of strategy formulator, while IT management 
played the role of strategy implementer. IT infrastructure became a cost center, measured by the 
degree to which IT facilitated achieving business goals, which in this case, it clearly did. The broad 
presentation of the results via the BPM system is perhaps the most significant contribution of IT to the 
organizational transformation, as evident in the quantitative results, and enforced by the qualitative 
ones. The BPM system clearly drove rapid change in employees' and mid-management way of 
conducting routine tasks, aimed at achieving the set goals.
Extending the discussion somewhat beyond SAM, (Tallon et al. 2000) identify three types of focused 
organizations: operations-focused, market-focused, or dual-focused. Dual-focused organizations 
improve operational effectiveness (internal perspective) and strategic positioning (external 
perspective) simultaneously, achieving the highest value from business and IT alignment. MHMO 
clearly demonstrates such a focus, since the improved quality of clinical care enables re-positioning in 
the market vis-à-vis competitors, whereas the contained costs mean improved internal processes.
Although a specific HMO has been the focus of this study, the lessons learned may, after more 
research is conducted, apply to other organizations as well, in the healthcare industry and beyond. 
First, this study demonstrates the plausibility of measuring quality of clinical care, and the positive 
effect that might be accrued. While generally considered complex and costly (Spath 2007), the 
described case suggests ways quality improvement can be achieved in healthcare without incurring 
excessive costs. Second, it shows how data for such measurements can be collected through 
infrastructural, routinely used operational IT, with only minimal requirements for special systems 
(such as the BPM system). This, however, is possible by careful planning for adequate IT 
infrastructure, processes and skills, developed in parallel to similar adjustments in business 
infrastructure. Evidently, such alignment can facilitate an organizational transformation from 
internally focused on costs to also externally focused, in this case on quality of care. Hence, this study
clearly demonstrates benefits accrued through business and IT alignment, where such alignment 
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Appendix 1: Annual performance in selected quality measures - HMO versus all other HMOs in the country: 2002-2005.
Year 2002 2003 2004 2005 2002 2003 2004 2005 2002 2003 2004 2005
Measure
1) % members with DM tested for HbA1c 
(DM1)
2) % members with DM with HbA1c < 7% 
(DM2)
3) % members with DM with 
HbA1c > 9% (DM3) [less is better]
HMO 86.72 96.72 98.01 98.72 N.A 41.82 44.32 51.55 N.A 16.14 14.48 12.08
Other 80.71 83.15 86.19 87.79 37.81 41.99 39.80 40.83 22.73 18.14 18.54 17.40
Measure 4) % members with DM tested for LDL (DM4)
5) % members with DM with LDL < 100 
mg/dl (DM5)
6) % members with DM with 
LDL < 130 mg/dl (DM6)
HMO 86.31 87.91 89.64 91.07 36.85 34.09 38.15 43.92 71.31 68.99 72.84 76.63
Other 80.69 82.75 85.69 86.07 37.52 40.21 44.36 48.59 72.75 75.08 77.91 80.49
Measure 7) % members with DM with an eye test (DM7)
8) % members with DM with urine testing 
for microalbumin (DM8)
9) % members with DM receiving flu vaccine 
(DM9)
HMO 58.19 58.58 60.32 63.25 50.19 54.77 58.69 65.85 42.79 49.73 60.20 58.93
Other 57.02 56.12 57.19 58.29 32.25 35.94 47.27 53.68 35.40 36.57 39.32 44.58
Measure
10) % women ages 52-74 having mammography 
in last 2 years (Mamm)
11) % of members ages  65+      receiving 
influenza vaccine (Vacc)
12) % of members ages 35-54 with LDL<130 
mg/dl (CVD1)
HMO 51.79 43.97 51.53 62.81 46.12 51.51 59.96 59.41 N.A. 58.94 57.94 57.56
Other 51.12 53.39 52.63 53.87 45.04 42.57 46.03 48.90 N.A. 63.07 63.76 65.50
Measure
13) % of members ages 55-74 with LDL<130 
mg/dl (CVD2)
14) % of patients with history of coronary 
artery bypass surgery with LDL<100 
mg/dl (CDV3)
15) % of members with history of coronary 
angiography with LDL<100 mg/dl 9CVD4)
HMO N.A. 52.18 54.88 57.81 N.A. 41.14 44.35 53.29 N.A. 41.27 45.91 53.05
Other N.A. 59.77 63.08 66.23 N.A. 46.98 52.55 57.14 N.A. 50.64 54.54 59.24
Measure
16) % of patients with history of coronary artery 
bypass surgery treated with statins (CVD5)
17) % of members with coronary 
angiography treated with statins (CVD6)
18) % of patients with history of coronary 
artery bypass surgery who were treated with 
ACEI/ARB (CVD7)
HMO N.A. 83.80 87.76 89.86 N.A. 76.98 81.48 84.39 N.A. 44.54 47.96 89.86
Other N.A. 70.78 74.26 77.77 N.A. 74.90 77.51 80.31 N.A. 75.51 78.56 77.77
Measure
19) % of  members with coronary angiography 
who treated with ACEI/ARB (CVD8)
20) % of  patients with history of coronary 
artery bypass treated with beta blocker 
(CVD9)
21) % of members with history of coronary 
angiography treated with beta blocker 
(CVD10)
HMO N.A. 47.28 50.12 84.39 N.A. 60.98 64.42 68.20 N.A. 64.74 66.75 69.12
Other N.A. 83.95 86.48 80.31 N.A. 63.63 66.93 68.82 N.A. 66.07 67.89 68.80
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* For CVD measures and DM2, DM3: 2002 data is not available. Comparisons were made to 2003
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† Patients with history of coronary artery bypass surgery





n.s:  Not significant
Appendix 3: Multivariate logistic regression analysis
(1)











BPM System Effect 
(Interaction)
OR (95% CI)
% tested HbA1c 1.475 (1.456 – 1.493) 2.545 (2.471 – 2.623) 3.552 (3.335 – 3.785)
% HbA1c<7% 0.934 (0,923 -0.946) 2 n.s. 1.380 (1.341 – 1.420)
% HbA1c>9% n.s. 0.69 (0.841 – 0.897) 0.802 (0.772 – 0.835)
%LDLtest 1.358 (1.342 – 1.375) 1.516 (1.479 – 1.554) n.s.
%LDL<130 1.343 (1.328 – 1.359) 0.824 (0.808 – 0.840) 0.946 (0.920 – 0.972)
%LDL<100 1.366 (1.353 – 1.380) 0.859 (0.843 – 0.875) 0.936 (0.913 – 0.960)
%Eyetest 1.050 (1.041 – 1.060) 1.078 (1.060 – 1.097) 1.100 (1.075 – 1.125)
%Urinetest 1.973 (1.955 – 1.991) 2.142 (2.106 – 2.179) 0.758 (0.741 – 0.776)
Diabetes (DM 1-9)
%DM Vaccine 1.288 (1.277 – 1.300) 1.544 (1.518 – 1.570) 1.315 (1.285 – 1.346)
Mammography %Mammography 1.040 (1.035 – 1.046) 0.834 (0.826 – 0.842) 1.413 (1.395 – 1.431)
Vaccine (Vacc) %Vaccine 1.162 (1.156 – 1.168) 1.232 (1.220 – 1.245) 1.329 (1.311 – 1.347)
%LDL<130 
( age 35-54)
1.072 (1.065 – 1.078) 0.841 (0.833 – 0.849) 0.888 (0.878 – 0.898)
%LDL<130 
(age 55-74)
1.233 (1.223 – 1.242) 0.734 (0.724 – 0.744) 0.962 (0.947 – 0.978)
%LDL<100† 1.371 (1.310 – 1.434) 0.789 (0.706 – 0.882) n.s.
%LDL<100†† 1.293 (1.251 – 1.336) 0.685 (0.647 – 0.726) 1.087 (1.015 – 1.164) 1
%Statin† 1.308 (1.249 – 1.370) 2.136 (1.867 – 2.451) n.s.
%Statin†† 1.260 (1.217 – 1.304) 1.121 (1.054 – 1.191) 3 1.159 (1.076 – 1.250) 3
%Ace† 1.161 (1.106 – 1.219) 0.260 (0.235 – 0.289) 2.241 (1.960 – 2.565)
%Ace†† 0.949 (0.912 – 0.988)1 0.171 (0.162 – 0.181) 2.505 (2.340 – 2.681)
%BetaBlocker† 1.207 (1.156 – 1.260) 0.893 (0.805 – 0.993) 1 n.s.
CVD (1-10)
%BetaBlocker†† 1.110  (1.076 – 1.145) 0.943 (0.893 – 0.995) 1 n.s.
